Status:
UNKNOWN
Telemonitoring in NIV MND (OptNIVent)
Lead Sponsor:
Liverpool University Hospitals NHS Foundation Trust
Conditions:
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a feasibility study of telemonitoring system for people with MND/ALS, who are on NIV, via a call centre operated by a local clinical commissioning group.
Detailed Description
This study will test the feasibility of previously developed Telehealth system, using a device called Careportal®, to monitor people with MND/ALS who are using non-invasive ventilation (NIV). The Care...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Patients):
- Confirmed diagnosis of MND with respiratory muscle weakness
- Adults who are capable of informed consent
- Patients for whom we anticipate survival of 6 months or more
- Able to communicate with an interviewer. Alternative communication methods will be used as required in order to mitigate communication difficulties.
- Exclusion Criteria (Patients):
- Patients who have declined NIV
Exclusion
Key Trial Info
Start Date :
April 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05299372
Start Date
April 25 2022
End Date
December 31 2022
Last Update
March 29 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.